Share Email Print
cover

Proceedings Paper

A clinical probe for combined Raman spectroscopy-optical coherence tomography (RS-OCT) of the skin cancers
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Skin cancer is the most commonly occurring cancer, with incidence rates rising annually. Realizing favorable outcomes requires early diagnosis, for which the current standard is biopsy followed by histopathology. This process can be invasive, subjective, time consuming, and costly. Optical techniques, including Optical Coherence Tomography (OCT) and Raman Spectroscopy (RS), have been developed to perform non-invasive characterization of skin lesions, however neither is without limitation. Here, we demonstrate a clinical instrument for morphological and biochemical characterization of skin cancers with combined RS-OCT. The portable instrument utilizes independent RS and OCT system backbones, and is integrated in a common clinical probe. The potential of the probe for cancer diagnosis is demonstrated on malignant and non-malignant lesions.

Paper Details

Date Published: 2 March 2010
PDF: 6 pages
Proc. SPIE 7548, Photonic Therapeutics and Diagnostics VI, 75480L (2 March 2010); doi: 10.1117/12.843708
Show Author Affiliations
Chetan A. Patil, Vanderbilt Univ. (United States)
Harish Krishnamoorthi, Vanderbilt Univ. (United States)
Darrel L. Ellis, Vanderbilt Univ. (United States)
Ton G. van Leeuwen, Amsterdam Medical Ctr. (Netherlands)
Anita Mahadevan-Jansen, Vanderbilt Univ. (United States)


Published in SPIE Proceedings Vol. 7548:
Photonic Therapeutics and Diagnostics VI
Anita Mahadevan-Jansen; E. Duco Jansen; Andreas Mandelis; Brian Jet-Fei Wong; Justus F. R. Ilgner; Nikiforos Kollias; Bernard Choi; Haishan Zeng; Henry Hirschberg; Steen J. Madsen; Kenton W. Gregory; Guillermo J. Tearney; Laura Marcu; Reza S. Malek, Editor(s)

© SPIE. Terms of Use
Back to Top